Nutex Health Inc.
NUTXNasdaqCIK 1479681IndustrialsFiscal year ends Dec 31
Reports and events: 226 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-11-2416:06 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001607062-21-000563 |
| 2021-11-1514:24 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001607062-21-000537 |
| 2021-10-2116:58 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001607062-21-000440 |
| 2021-10-0117:19 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001607062-21-000375 |
| 2021-08-1613:13 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001607062-21-000272 |
| 2021-07-2210:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001607062-21-000235 |
| 2021-05-2417:25 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001607062-21-000142 |
| 2021-05-2417:43 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001607062-21-000138 |
| 2021-05-2112:43 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001607062-21-000136 |
| 2021-04-1317:12 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001607062-21-000081 |
| 2021-04-0519:58 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001607062-21-000074 |
| 2021-03-0513:03 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001607062-21-000041 |
| 2021-03-0215:34 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001607062-21-000039 |
| 2020-11-1613:30 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001607062-20-000329 |
| 2020-09-2308:24 ET | 10-Q/A | Quarterly report, amendedPeriod 2020-06-30 | 0001607062-20-000289 |
| 2020-09-0817:18 ET | 8-K | 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits | 0001607062-20-000259 |
| 2020-08-2421:06 ET | 10-Q/A | Quarterly report, amendedPeriod 2020-06-30 | 0001607062-20-000246 |
| 2020-08-1917:21 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001607062-20-000238 |
| 2020-07-1515:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001607062-20-000197 |
| 2020-07-0216:34 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001607062-20-000193 |
| 2020-06-2912:10 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001607062-20-000189 |
| 2020-06-0315:35 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001607062-20-000142 |
| 2020-05-1914:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001607062-20-000137 |
| 2020-05-1509:39 ET | 8-K | 8.01 Other events | 0001607062-20-000127 |
| 2020-05-1417:15 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001607062-20-000125 |
| 2020-04-1317:10 ET | 8-K | 8.01 Other events | 0001607062-20-000098 |
| 2019-11-2208:36 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001607062-19-000459 |
| 2019-11-1911:48 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001607062-19-000457 |
| 2019-11-1216:33 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001607062-19-000431 |
| 2019-11-0418:28 ET | 8-K | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001607062-19-000421 |
| 2019-08-2012:47 ET | 10-Q/A | Quarterly report, amendedPeriod 2019-06-30 | 0001607062-19-000346 |
| 2019-08-2018:02 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001607062-19-000343 |
| 2019-08-0911:55 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001607062-19-000314 |
| 2019-06-2712:54 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001607062-19-000284 |
| 2019-05-2014:35 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001607062-19-000235 |
| 2019-04-1714:09 ET | 10-K/A | Annual report, amendedPeriod 2018-12-31 | 0001607062-19-000163 |
| 2019-04-1616:46 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001607062-19-000159 |
| 2018-11-2012:35 ET | 10-Q/A | Quarterly report, amendedPeriod 2018-09-30 | 0001607062-18-000432 |
| 2018-11-2017:40 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001607062-18-000430 |
| 2018-10-2914:15 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001607062-18-000371 |
| 2018-09-1214:23 ET | 8-K/A | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001607062-18-000273 |
| 2018-09-1214:20 ET | 8-K/A | 3.03 Change to security holders’ rights; 5.01 Change in control; 9.01 Financial statements and exhibits | 0001607062-18-000271 |
| 2018-08-1414:54 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001607062-18-000246 |
| 2018-08-0616:04 ET | 8-K | 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001607062-18-000241 |
| 2018-06-1916:36 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001607062-18-000207 |
| 2018-05-1514:55 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001607062-18-000172 |
| 2018-04-1712:18 ET | 10-K | Annual reportPeriod 2017-12-31 | 0001607062-18-000127 |
| 2017-11-2014:22 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001607062-17-000400 |
| 2017-08-1814:20 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0001607062-17-000278 |
| 2017-07-2613:57 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001551163-17-000129 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.